First Do No Harm: Independent Medicines and Medical Devices Safety Review publishes its recommendations
The Independent Medicines and Medical Devices Safety Review, chaired by Baroness Julia Cumberlege, has today published its report. Titled 'First Do No Harm', it comes...
People with neurological conditions lose out due to COVID-19 delays
In a recent survey of more than 1600 people with neurological conditions, over 7 in 10 respondents said they had experienced delays to their...
Without support for services post COVID-19 mental health crisis awaits
The BMA is warning that we could face a post COVID-19 mental health crisis if urgent support not provided for services. The BMA says...
People with diabetes ‘forgotten’ amid imminent easing of lockdown
People with diabetes have been ‘forgotten’ amid imminent easing of lockdown according to Diabetes UK. They say that steps to ease lockdown and reopen...
New online tool pinpoints HIV health inequalities in England
A new online tool has been launched which pinpoints HIV health inequalities in England, it's hoped it will improve prevention and planning. The rate of...
COVID-19 forces radical changes in NHS finance
Oli Hudson, Content Director at Wilmington Healthcare, discusses how COVID-19 is forcing radical changes in NHS finance and gives an overview of the latest...
STADA Health Report 2020: The future of health in Europe
The second international STADA Health Report on the future of health in Europe shows how people in Europe handle future-oriented health topics. A topic which...
Impact of COVID-19 on private healthcare
New data shows the impact of COVID-19 on private healthcare in the UK. The pandemic has led to an estimated 84% drop in privately...
New osteoporosis partnership for post-fracture care
UCB and Amgen have announced a collaboration with the International Osteoporosis Foundation (IOF) to combat the global public health burden of osteoporosis and proactively...
New cancer blood test up to 10 times more sensitive
A new cancer blood test to analyse patients’ blood for evidence of the disease could be up to ten times more sensitive than previous...
Latest articles
The first self-administered B-cell therapy for patients with relapsing forms of MS
Novartis receives European and UK licence for Kesimpta®▼(ofatumumab) Ofatumumab is a self-administered targeted B-cell depleting treatment option for adult patients living with relapsing forms of...
MHRA new advice on possible link between COVID-19 Vaccine AstraZeneca and blood clots
The benefits of vaccination continue to outweigh any risks but the MHRA advises careful consideration be given to people who are at higher risk...
Thousands of patients set to benefit from five-minute breast cancer treatment
An injection that cuts the amount of time breast cancer patients spend in hospital from two and a half hours to as little as...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
MHRA new advice on possible link between COVID-19 Vaccine AstraZeneca and blood clots
The benefits of vaccination continue to outweigh any risks but the MHRA advises careful consideration be given to people who are at higher risk...
The first self-administered B-cell therapy for patients with relapsing forms of MS
Novartis receives European and UK licence for Kesimpta®▼(ofatumumab) Ofatumumab is a self-administered targeted B-cell depleting treatment option for adult patients living with relapsing forms of...
Twice weekly rapid COVID-19 testing to be available to everyone in England
Access to twice weekly, free, regular, rapid coronavirus (COVID-19) testing from 9 April for everyone in England, the Government has announced. Everyone in England,...
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...